8-KRegulation FDExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Regulation FD Disclosure (Apr 1, 2005)

Filed April 1, 2005For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) filed an 8-K on April 1, 2005, primarily to disclose information related to an upcoming investor presentation. CEO Robert D. Walter was scheduled to speak at the Lehman Brothers Eighth Annual Global Healthcare Conference on April 1, 2005. The presentation was expected to cover the company's products, services, financial performance, and growth strategies. This filing provides investors with access to the materials Mr. Walter would use, including a slide presentation furnished as Exhibit 99.01 and a related press release furnished as Exhibit 99.02. These documents would have offered insights into the company's operational and financial outlook as communicated directly by its CEO, and were made available via webcast and on the company's investor relations website.

Key Highlights

  • 1CEO Robert D. Walter scheduled to present at the Lehman Brothers Eighth Annual Global Healthcare Conference on April 1, 2005.
  • 2Presentation to cover Cardinal Health's diverse products, services, financial performance, and growth strategies.
  • 3Company furnished its slide presentation for the conference as Exhibit 99.01.
  • 4A related press release issued on April 1, 2005, was also furnished as Exhibit 99.02.
  • 5The presentation was webcast live, with an archive available on the company's investor relations page.
  • 6This 8-K serves as a Regulation FD disclosure, ensuring broad public access to material information.

Frequently Asked Questions

The main purpose of this 8-K filing is to provide investors with access to information that CEO Robert D. Walter would be presenting at the Lehman Brothers Eighth Annual Global Healthcare Conference. This includes furnishing the slide presentation and a press release.

Investors could access the slide presentation (Exhibit 99.01) and the press release (Exhibit 99.02) attached to this 8-K filing. Additionally, the presentation was webcast live, and an archive of both the webcast and presentation was made available on Cardinal Health's investor relations website for at least 30 days.

The CEO's presentation was slated to discuss Cardinal Health's diverse products and services, its financial performance, and its strategies for continued growth.

This 8-K filing primarily concerns the disclosure of materials for an investor presentation and does not appear to introduce new financial data or specific guidance beyond what was communicated in the furnished exhibits. Investors would need to review Exhibits 99.01 and 99.02 for the specific details shared at the conference.